The 10th International Conference on Alzheimer’s and Parkinson’s Diseases: Post-Conference Review and Analysis
Phosphodiesterase 9 (PDE9 or EC 3.1.4.35) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players